Trial intelligence / Profile preview

Remimazolam tosylate versus propofol for sedation during routine gastroscopy

ChiCTR2000032067Phase 4Recruiting

Sponsor
Department of Anesthesiology, the First People's Hospital of Lianyungang City
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam and propofol in None (2 arms), sponsored by Department of Anesthesiology, the First People's Hospital of Lianyungang City. Primary endpoint: Sedation success rate. Started Apr 2020; status: recruiting.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on ChiCTR2000032067.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000032067.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call